Please provide your email address to receive an email when new articles are posted on . Amitriptyline was superior to placebo and increased the odds of relief from IBS symptoms. Researchers noted that ...

Irritable Bowel Syndrome (IBS) is a complex and often frustrating condition affecting millions worldwide. Finding effective treatments can be challenging, but a recent clinical trial has shed light on ...

Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...

Researchers conducted a pragmatic, randomized, placebo-controlled, phase 3 trial, in collaboration with 64 general practices in Amsterdam, to evaluate the effectiveness of low doses of the ...